Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
1.390
-0.030 (-2.11%)
At close: Sep 15, 2025, 4:00 PM EDT
1.410
+0.020 (1.44%)
After-hours: Sep 15, 2025, 5:22 PM EDT
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $109.23 million as of September 15, 2025. Its market cap has increased by 36.73% in one year.
Market Cap
109.23M
Enterprise Value
84.06M
1-Year Change
36.73%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has increased from $45.05M to $109.23M, an increase of 142.49%. That is a compound annual growth rate of 21.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 111.59M | 73.82% |
| Dec 31, 2024 | 64.19M | -19.95% |
| Dec 29, 2023 | 80.19M | 35.27% |
| Dec 30, 2022 | 59.28M | -88.32% |
| Dec 31, 2021 | 507.73M | 1,027.17% |
| Jan 27, 2021 | 45.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |